Meet Maverex in Vienna at ISPOR Europe 2026

8–11 November 2026 | Vienna, Austria | Stand 711, Level -2, Hall X2

A chance to connect

The Maverex team will be at ISPOR Europe 2026 from 8–11 November. See who's attending below and book a time to talk with any of us.

We’re also presenting our research, including a podium presentation:

Estimating Greenhouse Gas Emissions Avoided Through HPV Vaccination in Cervical Cancer and CIN3 Care Pathways
Monday 9 November, 10:30–11:30 CET | Room TBC | Presented by Cheryl Jones, Head of Environmental Modelling

We look forward to seeing you there!

See who’s attending and book a meeting

Book a meeting

Our research schedule at ISPOR Europe 2026

We’re presenting eight posters and one podium presentation, covering topics across HEOR and market access.

.

Podium Presentation

Estimating Greenhouse Gas Emissions Avoided Through HPV Vaccination in Cervical Cancer and CIN3 Care Pathways
Presented by: Cheryl Jones

Room TBC | Monday 9 November, 10:30–11:30 CET

Poster Presentations

Poster Session 1 | Monday 9 November, 10:30–13:30 CET

Transportability Methods for RWE – HTA Acceptability and Methodological Guidance - HTA43
Presented by: Anne Wilson
How Immature Is Too Immature? OS Data Trends in NICE HTA Submissions - CO30
Presented by: Steph Stephens

Poster Session 2 | Monday 9 November, 16:00–19:00 CET

Modelling Patient Travel in Environmental Sustainability Assessments of Care Pathways: Methodological Solutions for Data-Scarce Settings - MSR76
Presented by: Cheryl Jones
Why Is Environmental Sustainability Evidence Difficult to Identify? A Bibliometric Analysis Reveals Gaps in Indexing, Database Coverage, and Publication Coverage - MSR117
Presented by: Nick Pooley
Payer and Regulator Evidence Requirements for Clinical Outcome Assessments: A Comparative Review of US, English, European and Canadian Guidance - MSR119
Presented by: Rhiannon Chan

Poster Session 3 | Tuesday 10 November, 10:30–13:30 CET

When Does Environmental Impact Add Value to Cost-Utility Analysis? A Proof-of-Concept Application in Severe Asthma Biologics - PT23
Selected for Poster Tour, presented by: Steph Stephens

Poster Session 5 | Wednesday 11 November, 9:00–11:30 CET

Pipeline Review of Traditional Small Molecule Antibacterial Medicines - HPR226
Presented by: Nick Pooley
Trends and Drivers in Cancer Drugs Fund Use in Non-Small Cell Lung Cancer - HTA342
Presented by: Lizzie Adkins

Connect

Members of the Maverex Team are on hand to help answer your questions and queries at the stand. They’re just some of our dedicated team, why not meet the rest?

Meet the team
Discover

Our specialised cross-functional teams work across all market access needs. From Evidence Generation to Economic and Environmental Modelling, explore our full range of services.

Our services
Explore

Our customers value the services and high-quality deliverables we provide, and they continue to work with us again and again. Explore some of our recent publications.

Publications

Recent feedback

"The best experience in GVD development I had. It was really streamlined and made a very good impression to our new management. We cannot thank you enough! "

Global Health Economics Director, Top 5 Global Biopharma Company
"Maverex always gives that bit extra. I know I can rely on them to provide strategic advice when I need it and they are able to react flexibly to changing project needs. I value that highly."

Health Economics & Market Access Director, Start-up biopharma company
"The best analytical professional consultancy that I have worked with so far. No nonsense, they deliver high quality work, and a pleasure to work with."

Reimbursement and Market Access Manager, Top 20 global biopharma company